109132 ⎘
Structure or type of the nucleic acid; Type of nucleic acid Antisense
Chimeric double-stranded nucleic acid
#2702Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2703Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2704Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2705Identification and use of target genes for control of plant parasitic nematodes
#2706Methods of treatment using antisense oligomers and conjugates targeting PCSK9
#2707Manufacture of antisense oligomers and conjugates targeting PCSK9
#2708MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2)
#2709COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE
#2710Method of treating delayed healing of a wound associated with diabetes
#2711Nanoparticle formulations for delivery of nucleic acid complexes
#2712Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#2713Antisense oligonucleotides for the treatment of leber congenital amaurosis
#2714MicroRNA Compounds and Methods for Modulating MIR-21 Activity
#2715SARNA COMPOSITIONS AND METHODS OF USE
#2716Linkage modified oligomeric compounds
#2717METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2718METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2719Methods and compositions involving transmembrane and coiled-coil domains 3 (TM-CO3) in cancer
#2720COMPOSITIONS AND METHODS FOR MODULATING SMN GENE FAMILY EXPRESSION
#2721Peptide oligonucleotide conjugates
#2722Modified AAV constructs and uses thereof
#2723Methods and compositions for treating aging-associated impairments
#2724TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE
#2725Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish
#2726Methods for diagnosing Huntington's disease
#2727SELECTIVE REDUCTION OF ALLELIC VARIANTS
#2728USP30 INHIBITORS AND METHODS OF USE
#2729Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#2730METHODS AND COMPOSITIONS FOR PROMOTING HAIR GROWTH
#2731COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
#2732Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos
#2733Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2734Therapeutic agent for sarcopenia and metabolic diseases
#2735Oligonucleotides for modulating gene expression and uses thereof
#2736Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics
#2737Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
#2738Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
#2739Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
#2740FALZ for use as a target for therapies to treat cancer
#2741METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2742Induced exon inclusion in spinal muscle atrophy
#2743Compositions and methods for modulating apolipoprotein (a) expression
#2744Compositions and methods for modulating apolipoprotein C-III expression
#2745MODULATION OF TRANSTHYRETIN EXPRESSION
#2746MODULATION OF TRANSTHYRETIN EXPRESSION
#2747Compositions and their uses directed to huntingtin
#2748Modulation of SMN expression
#2749Methods and compositions related to increased influenza virus production
#2750MODULATORS OF KRAS EXPRESSION
#2751Biodegradable lipids for delivery of nucleic acids
#2752Biodegradable lipids for delivery of nucleic acids
#2753Biodegradable lipids for delivery of nucleic acids
#2754Biodegradable lipids for delivery of nucleic acids
#2755Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes
#2756Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
#2757MODIFIED 3' REGION EXTRACTION AND DEEP SEQUENCING OF POLYDENYLATION SITES AND POLY(A) TAIL LENGTH ANALYSIS
#2758AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#2759Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage (3dT)
#2760Antisense nucleic acids
#2761Renal selective inhibition of cytochrome P450 3A5
#2762Modified iRNA agents
#2763Compounds for inducing anti-tumor immunity and methods thereof
#2764Compositions and methods for modulating Ataxin 3 expression
#2765METHOD OF IDENTIFYING GENOME-WIDE OFF-TARGET SITES OF BASE EDITORS BY DETECTING SINGLE STRAND BREAKS IN GENOMIC DNA
#2766Compositions and methods for modulating FMR1 expression
#2767Methods and compositions for modulating apolipoprotein (a) expression
#2768METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2769METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2770METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2771METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2772Antisense oligonucleotide compositions
#2773Oligonucleotide conjugates
#2774Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#2775Antisense nucleic acid for treating amyotrophy
#2776METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2777METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2778COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#2779Polycomb-associated non-coding RNAs
#2780Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa
#2781MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPODYSTROPHY POPULATIONS
#2782METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2783Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates
#2784ANTISENSE DESIGN
#2785ANTISENSE DESIGN
#2786Methods and compositions for modlating apolipoprotein (A) expression
#2787ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
#2788Splice-region antisense composition and method
#2789Compositions and methods of using anti-mullerian hormone for treatment of infertility
#2790Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes
#2791ANTISENSE COMPOSITIONS TARGETING ERWINIA SPECIES AND METHODS OF USING THE SAME
#2792METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2793METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2794METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2795Modified TGF-beta oligonucleotides
#2796Methods of identifying and treating poor-prognosis cancers
#2797APTAMER-GUIDED GENE TARGETING
#2798Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#2799Brush polymer-assisted compaction of oligonucleotides
#2800METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#2801NUCLEIC ACID COMPLEX HAVING AT LEAST ONE BULGE STRUCTURE
#2802Modulation of TMPRSS6 expression
#2803COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#2804Compositions and methods for modulating MECP2 expression
#2805NUCLEIC ACID COMPLEX
#2806Functionally-modified oligonucleotides and subunits thereof
#2807Compositions and methods for treating leukemia
#2808SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS
#2809Sterile formulation comprising a stable phosphorothioate oligonucleotide
#2810Compositions and methods for modulating ABHD2 activity
#2811Antisense oligomers targeting PCSK9
#2812METHODS FOR REDUCING PROTEOTOXICITY
#2813ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
#2814MicroRNA-328 anti-sense composition and therapeutic use
#2815Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy
#2816METHOD FOR INDIVIDUALIZED CANCER THERAPY
#2817Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2818TREATMENT OF LIPID TRANSPORT AND METABOLISM GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A LIPID TRANSPORT AND METABOLISM GENE
#2819Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#2820ANTISENSE OLIGONUCLEOTIDE INHIBITING ß2GPI EXPRESSION
#2821PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#2822Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#2823Methods and compositions for treating cancers using antisense
#2824Compounds for inducing anti-tumor immunity and methods thereof
#2825COMPOUNDS AND METHODS FOR MODULATING TARGET NUCLEAR AND SUB-NUCLEAR NUCLEIC ACID MOLECULES IN CELLS AND ANIMALS
#2826Amine-containing transfection reagents and methods for making and using same
#2827Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
#2828SEPTIN PROTEINS AS NOVEL BIOMARKERS FOR DETECTION AND TREATMENT OF MÜLLERIAN CANCERS
#2829Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
#2830Fertility gene and use thereof
#2831Fertility gene and use thereof
#2832MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders
#2833Nucleic acid functionalized nanoparticles for therapeutic applications
#2834Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#2835Methods for treating inflammatory bowel disease
#2836OLIGONUCLEOTIDE TARGETING STRATEGY FOR cccDNA
#2837ANTISENSE NUCLEIC ACIDS
#2838MODULATION OF TRANSTHYRETIN EXPRESSION
#2839MODULATION OF TRANSTHYRETIN EXPRESSION
#2840MODULATION OF TRANSTHYRETIN EXPRESSION
#2841MODULATION OF TRANSTHYRETIN EXPRESSION
#2842MODULATION OF TRANSTHYRETIN EXPRESSION
#2843MODULATION OF TRANSTHYRETIN EXPRESSION
#2844MODULATION OF TRANSTHYRETIN EXPRESSION
#2845MODULATION OF TRANSTHYRETIN EXPRESSION
#2846MODULATION OF TRANSTHYRETIN EXPRESSION
#2847MODULATION OF TRANSTHYRETIN EXPRESSION
#2848COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#2849Vectors
#2850Antisense molecules and methods for treating pathologies
#2851Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#2852METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#2853Allele specific modulators of P23H rhodopsin
#2854Combined therapy for duchenne muscular dystrophy
#2855Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
#2856Lipid-derived neutral nanoparticles
#2857Lipid-derived neutral nanoparticles
#2858MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#2859Method for treatment of subjects with TUG1 gene expressing brain tumor
#2860ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#2861COMPOSITION AND METHODS FOR REGULATING INHIBITORY INTERACTIONS IN GENETICALLY ENGINEERED CELLS
#2862P-ethoxy nucleic acids for liposomal formulation
#2863Methods and compounds for treatment of lymphocyte-related diseases and conditions
#2864Tau antisense oligomers and uses thereof
#2865Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
#2866Restoration of the CFTR function by splicing modulation
#2867MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
#2868RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
#2869SMN2 element 1 antisense compositions and methods and uses thereof
#2870Compounds and methods for increasing antisense activity
#2871Antisense nucleic acids
#2872MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#2873Methods for modulating expression of C9ORF72 antisense transcript
#2874Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#2875Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
#2876Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#2877Compositions and methods for inhibiting expression of the LECT2 gene
#2878Modified oligonucleotides and methods of use
#2879Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
#2880Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#2881INDUCTION OF HEPATOCYTES BY STEM CELL DIFFERENTIATION WITH RNA
#2882Modulation of nuclear-retained RNA
#2883METHODS FOR CONTROLLING OBESITY USING MINIMALLY INVASIVE MEANS
#2884BIVALENT ANTISENSE OLIGONUCLEOTIDES
#2885ANTISENSE COMPOUNDS TARGETING GENES ASSOCIATED WITH FIBRONECTIN
#2886METHODS RELATING TO THE PREVENTION AND TREATMENT OF DRUG RESISTANCE
#28872′-arabino-fluorooligonucleotide N3′˜P5′ phosphoramidates: their synthesis and use
#2888Exonic splicing enhancers and exonic splicing silencers
#2889Androgen receptor variant inhibitors and methods of using
#2890Antisense compounds targeting genes associated with cystic fibrosis
#2891Compounds and methods for reducing Tau expression
#2892Therapeutic methods, products and compositions inhibiting ZNF555
#2893Compositions for modulating expression of C9ORF72 antisense transcript
#2894GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
#2895Therapy for malignant disease
#2896Antisense compounds targeting genes associated with cystic fibrosis
#2897Methods of inducing insulin production
#2898Targeting hepatitis B virus (HBV) host factors
#2899Treatment of genetic disorders associated with DNA repeat instability
#2900Targeted RNA knockdown and knockout by type III-A Csm complexes
#2901Compounds and methods for modulating TMPRSS6 expression
#2902METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#2903Multiple sclerosis treatment
#2904Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
#2905Click nucleic acid polymers and methods of use
#2906COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#2907Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
#2908Inhibitors of MYH7B and uses thereof
#2909Compositions for modulating Tau expression
#2910RNA nanoparticles and method of use thereof
#2911METHOD OF TREATMENT
#2912Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof
#2913Oligonucleotide analogues targeting human LMNA
#2914METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#2915TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2916Oligonucleotide compositions with enhanced efficiency
#2917MODIFIED TGF-BETA2 OLIGONUCLEOTIDES
#2918Modulation of huntingtin expression
#2919BGL7 Beta-Glucosidase and Nucleic Acids Encoding the Same
#2920METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES
#2921POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#2922Highly specific delivery of polynucleotides to the cell nucleus via compression
#2923Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping
#2924RNA-guided gene editing system and uses thereof
#2925NOVEL EXPRESSION REGULATING RNA-MOLECULES AND USES THEREOF
#2926Chimeric double-stranded nucleic acid
#2927Modulation of alpha synuclein expression
#2928MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#2929RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Neuromuscular Disorders
#2930RNA products and uses thereof
#2931Assay for telomere length regulators
#2932Hepcidin antagonists for use in the treatment of inflammation
#2933COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS
#2934COMPOSITIONS AND METHODS FOR MODULATING RNA
#2935Methods of treating an overweight subject
#2936Therapeutic nanoparticles and methods of use thereof
#2937Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#2938Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#2939Compositions and methods for modulating Tau expression
#2940ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#2941METHODS TO ENHANCE CELL-MEDIATED IMMUNITY
#2942Cholesteryl ester transfer protein (CETP) inhibition in the treatment of cancer
#2943Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
#2944Carriers for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States
#2945Composition for treating cancer associated with HPV infection
#2946Compositions and methods for modulating TTR expression
#2947Antisense nucleic acids
#2948METHODS FOR MODULATING MECP2 EXPRESSION
#2949COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THEREOF
#2950Insecticidal combinations of PIP-72 and methods of use
#2951Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#2952ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES
#2953Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#2954TARGETING OLIGONUCLEOTIDES AND USES THEREOF TO MODULATE GENE EXPRESSION
#2955Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#2956Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#2957Oligonucleotide therapy for leber congenital amaurosis
#2958Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides
#2959Oligomers Having Bicyclic Scaffold Moeities
#2960SUSTAINED RELEASE DRUG DELIVERY DEVICES
#2961Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#2962LNA OLIGONUCLEOTIDES WITH ALTERNATING FLANKS
#2963Compositions for modulating expression of C9ORF72 antisense transcript
#2964Antisense conjugates for decreasing expression of DMPK
#2965Morpholino oligonucleotide manufacturing method
#2966Methods for the treatment of Leber congenital amaurosis
#2967LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate Linkages
#2968EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#2969Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
#2970Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#2971Compositions and methods to promote erythropoiesis
#2972Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#2973ANTISENSE COMPOUNDS AND USES THEREOF
#2974Compounds and methods for the modulation of proteins
#2975Antisense oligonucleotides for modulating HTRA1 expression
#2976Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#2977COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS
#2978Reducing intron retention
#2979COMPOSITIONS AND METHODS
#2980Sequence Specific and Organism Specific Antimicrobials and Related Materials and Methods
#2981EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#2982Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
#2983MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION
#2984EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#2985EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#2986Compositions for enhancing transport of molecules into cells
#2987HPV particles and uses thereof
#2988Methods for treating spinal muscular atrophy
#2989Methods and materials for treating cancer
#2990Modulation of UBE3A-ATS expression
#2991ANTI-ARRHYTHMICITY AGENTS
#2992Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#2993Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#2994Modulation of alternative MDM2 splicing
#2995ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#2996Conjugated antisense compounds and their use
#2997Methods of using gap junctions as therapeutic targets for the treatment of degenerative disorders of the retina
#2998Compositions for modulating C9ORF72 expression
#2999METHODS FOR TREATING HYPERCHOLESTEROLEMIA
#3000Compositions and methods for treating pancreatic cancer